F2 and neoplasm: Beyond its classical function in hemostasis, emerging evidence links abnormalities involving coagulation factor II and related pathways to tumor metastasis (Teofilov et al., 2025), angiogenesis (Kvasnička et al., 2024), and disease severity (PMID: 39497411).